New Federal Buprenorphine Guidelines Reduce Barriers to Treatment
April 28, 2021
The purpose of this bulletin is to inform hospitals about the new buprenorphine practice guidelines issued by the Department of Health and Human Services (HHS), effective April 28, 2021. The new guidance removes a key barrier to obtaining an X-Waiver for prescribing buprenorphine by exempting covered practitioners from certain requirements. This regulatory change will make it easier for practitioners to obtain an X-Waiver to prescribe buprenorphine to patients with opioid use disorder (OUD).... Read More >>